Board of Scientific Counselors, National Center for Injury Prevention and Control, (BSC, NCIPC), 10441-10442 [2020-03584]
Download as PDF
<![CDATA[
lotter on DSKBCFDHB2PROD with NOTICES
Federal Register / Vol. 85, No. 36 / Monday, February 24, 2020 / Notices
may be invited to serve for four-year
terms.
Selection of members is based on
candidates’ qualifications to contribute
to the accomplishment of HICPAC
objectives https://www.cdc.gov/hicpac/.
DATES: Nominations for membership on
the HICPAC must be received no later
than August 3, 2020. Packages received
after this time will not be considered for
the current membership cycle.
ADDRESSES: All nominations should be
mailed to HICPAC, Division of
Healthcare Quality Promotion, NCEZID,
CDC, 1600 Clifton Road NE, Mailstop
H16–3, Atlanta, Georgia 30329–4027,
emailed (recommended) to hicpac@
cdc.gov, or faxed to (404) 639–4043.
FOR FURTHER INFORMATION CONTACT: KooWhang Chung, MPH, HICPAC, Division
of Healthcare Quality Promotion,
NCEZID, CDC, 1600 Clifton Road NE,
Mailstop H16–3, Atlanta, Georgia
30329–4027; hicpac@cdc.gov.
SUPPLEMENTARY INFORMATION: The U.S.
Department of Health and Human
Services policy stipulates that
committee membership be balanced in
terms of points of view represented, and
the committee’s function. Appointments
shall be made without discrimination
on the basis of age, race, ethnicity,
gender, sexual orientation, gender
identity, HIV status, disability, and
cultural, religious, or socioeconomic
status. Nominees must be U.S. citizens,
and cannot be full-time employees of
the U.S. Government. Current
participation on federal workgroups or
prior experience serving on a federal
advisory committee does not disqualify
a candidate; however, HHS policy is to
avoid excessive individual service on
advisory committees and multiple
committee memberships. Committee
members are Special Government
Employees (SGEs), requiring the filing
of financial disclosure reports at the
beginning and annually during their
terms. CDC reviews potential candidates
for HICPAC membership each year and
provides a slate of nominees for
consideration to the Secretary of HHS
for final selection. HHS notifies selected
candidates of their appointment near
the start of the term in July 2021, or as
soon as the HHS selection process is
completed. Note that the need for
different expertise varies from year to
year and a candidate who is not selected
in one year may be reconsidered in a
subsequent year. SGE Nominees must be
U.S. citizens, and cannot be full-time
employees of the U.S. Government.
Candidates should submit the following
items:
D Current curriculum vitae, including
complete contact information
VerDate Sep<11>2014
18:30 Feb 21, 2020
Jkt 250001
(telephone numbers, mailing address,
email address).
D At least one letter of
recommendation from person(s) not
employed by the U.S. Department of
Health and Human Services.
(Candidates may submit letter(s) from
current HHS employees if they wish,
but at least one letter must be submitted
by a person not employed by an HHS
agency (e.g., CDC, NIH, FDA, etc.).
Nominations may be submitted by the
candidate him- or herself, or by the
person/organization recommending the
candidate.
The Director, Strategic Business
Initiatives Unit, Office of the Chief
Operating Officer, Centers for Disease
Control and Prevention, has been
delegated the authority to sign Federal
Register notices pertaining to
announcements of meetings and other
committee management activities, for
both the Centers for Disease Control and
Prevention and the Agency for Toxic
Substances and Disease Registry.
Kalwant Smagh,
Director, Strategic Business Initiatives Unit,
Office of the Chief Operating Officer, Centers
for Disease Control and Prevention.
[FR Doc. 2020–03585 Filed 2–21–20; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
Board of Scientific Counselors,
National Center for Injury Prevention
and Control, (BSC, NCIPC)
Centers for Disease Control and
Prevention (CDC), Department of Health
and Human Services (HHS).
ACTION: Notice of meeting.
AGENCY:
In accordance with the
Federal Advisory Committee Act, the
CDC announces the following meeting
for the Board of Scientific Counselors,
National Center for Injury Prevention
and Control, (BSC, NCIPC). This
meeting is open to the public limited
only by the space and ports available.
There will be 2,000 telephone ports
available. There will be a public
comment period at the end of the
meeting; from 3:00 p.m.–3:45 p.m., EDT.
DATES: The meeting will be held on
April 30, 2020, 12:30 p.m. to 3:50 p.m.,
EDT.
ADDRESSES: Teleconference: Dial-In
Number: 1–800–369–3110, Participant
Code: 7563795.
FOR FURTHER INFORMATION CONTACT:
Gwendolyn H. Cattledge, Ph.D.,
SUMMARY:
PO 00000
Frm 00044
Fmt 4703
Sfmt 4703
10441
M.S.E.H., Deputy Associate Director for
Science, NCIPC, CDC, 4770 Buford
Highway NE, Mailstop F–63, Atlanta,
GA 30341, Telephone (770) 488–1430;
Email address: ncipcbsc@cdc.gov.
SUPPLEMENTARY INFORMATION:
Purpose: The Board will: (1) Conduct,
encourage, cooperate with, and assist
other appropriate public health
authorities, scientific institutions, and
scientists in the conduct of research,
investigations, experiments,
demonstrations, and studies relating to
the causes, diagnosis, treatment, control,
and prevention of physical and mental
diseases, and other impairments; (2)
assist States and their political
subdivisions in preventing and
suppressing communicable and noncommunicable diseases and other
preventable conditions and in
promoting health and well-being; and
(3) conduct and assist in research and
control activities related to injury. The
Board of Scientific Counselors makes
recommendations regarding policies,
strategies, objectives, and priorities; and
reviews progress toward injury
prevention goals and provides evidence
in injury prevention-related research
and programs. The Board also provides
advice on the appropriate balance of
intramural and extramural research, the
structure, progress and performance of
intramural programs. The Board is
designed to provide guidance on
extramural scientific program matters,
including the: (1) Review of extramural
research concepts for funding
opportunity announcements; (2)
conduct of Secondary Peer Review of
extramural research grants, cooperative
agreements, and contracts applications
received in response to the funding
opportunity announcements as it relates
to the Center’s programmatic balance
and mission; (3) submission of
secondary review recommendations to
the Center Director of applications to be
considered for funding support; (4)
review of research portfolios; and (5)
review of program proposals.
Matters To Be Considered: The agenda
will discuss an update on the CDC
Opioid Prescribing Estimates Project,
the Management of Acute and Chronic
Pain: Opportunities for Stakeholder
Engagement, and Public Comments. In
addition, an update will be provided on
the formation of the BSC, NCIPC Opioid
Workgroup. Agenda items are subject to
change as priorities dictate.
The Director, Strategic Business
Initiatives Unit, Office of the Chief
Operating Officer, Centers for Disease
Control and Prevention, has been
delegated the authority to sign Federal
Register notices pertaining to
E:\FR\FM\24FEN1.SGM
24FEN1
10442
Federal Register / Vol. 85, No. 36 / Monday, February 24, 2020 / Notices
announcements of meetings and other
committee management activities, for
both the Centers for Disease Control and
Prevention and the Agency for Toxic
Substances and Disease Registry.
Kalwant Smagh,
Director, Strategic Business Initiatives Unit,
Office of the Chief Operating Officer, Centers
for Disease Control and Prevention.
[FR Doc. 2020–03584 Filed 2–21–20; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Medicare & Medicaid
Services
[Document Identifier: CMS–1728–19, CMS–
10714 and CMS–484, 846, 847, 848, 849,
10125, 10126]
Agency Information Collection
Activities: Submission for OMB
Review; Comment Request
Centers for Medicare &
Medicaid Services, HHS.
ACTION: Notice.
AGENCY:
The Centers for Medicare &
Medicaid Services (CMS) is announcing
an opportunity for the public to
comment on CMS’ intention to collect
information from the public. Under the
Paperwork Reduction Act of 1995
(PRA), federal agencies are required to
publish notice in the Federal Register
concerning each proposed collection of
information, including each proposed
extension or reinstatement of an existing
collection of information, and to allow
a second opportunity for public
comment on the notice. Interested
persons are invited to send comments
regarding the burden estimate or any
other aspect of this collection of
information, including the necessity and
utility of the proposed information
collection for the proper performance of
the agency’s functions, the accuracy of
the estimated burden, ways to enhance
the quality, utility, and clarity of the
information to be collected, and the use
of automated collection techniques or
other forms of information technology to
minimize the information collection
burden.
SUMMARY:
Comments on the collection(s) of
information must be received by the
OMB desk officer by March 25, 2020.
ADDRESSES: When commenting on the
proposed information collections,
please reference the document identifier
or OMB control number. To be assured
consideration, comments and
recommendations must be received by
the OMB desk officer via one of the
lotter on DSKBCFDHB2PROD with NOTICES
DATES:
VerDate Sep<11>2014
18:30 Feb 21, 2020
Jkt 250001
following transmissions: OMB, Office of
Information and Regulatory Affairs,
Attention: CMS Desk Officer, Fax
Number: (202) 395–5806 OR Email:
OIRA_submission@omb.eop.gov.
To obtain copies of a supporting
statement and any related forms for the
proposed collection(s) summarized in
this notice, you may make your request
using one of following:
1. Access CMS’ website address at
website address at https://www.cms.gov/
Regulations-and-Guidance/Legislation/
PaperworkReductionActof1995/PRAListing.html.
1. Email your request, including your
address, phone number, OMB number,
and CMS document identifier, to
Paperwork@cms.hhs.gov.
2. Call the Reports Clearance Office at
(410) 786–1326.
FOR FURTHER INFORMATION CONTACT:
William Parham at (410) 786–4669.
SUPPLEMENTARY INFORMATION: Under the
Paperwork Reduction Act of 1995 (PRA)
(44 U.S.C. 3501–3520), federal agencies
must obtain approval from the Office of
Management and Budget (OMB) for each
collection of information they conduct
or sponsor. The term ‘‘collection of
information’’ is defined in 44 U.S.C.
3502(3) and 5 CFR 1320.3(c) and
includes agency requests or
requirements that members of the public
submit reports, keep records, or provide
information to a third party. Section
3506(c)(2)(A) of the PRA (44 U.S.C.
3506(c)(2)(A)) requires federal agencies
to publish a 30-day notice in the
Federal Register concerning each
proposed collection of information,
including each proposed extension or
reinstatement of an existing collection
of information, before submitting the
collection to OMB for approval. To
comply with this requirement, CMS is
publishing this notice that summarizes
the following proposed collection(s) of
information for public comment:
1. Type of Information Collection
Request: Revision of a currently
approved collection; Title of
Information Collection: Home Health
Agency Cost Report; Use: Under the
authority of sections 1815(a) and
1833(e) of the Social Security Act (42
U.S.C. 1395g), CMS requires that
providers of services participating in the
Medicare program submit information
to determine costs for health care
services rendered to Medicare
beneficiaries. CMS requires that
providers follow reasonable cost
principles under 1861(v)(1)(A) of the
Act when completing the Medicare cost
report. Under the regulations at 42 CFR
413.20 and 413.24, CMS defines
adequate cost data and requires cost
PO 00000
Frm 00045
Fmt 4703
Sfmt 4703
reports from providers on an annual
basis. The Form CMS–1728–19 cost
report is needed to determine a
provider’s reasonable cost incurred in
furnishing medical services to Medicare
beneficiaries and reimbursement due to
or from a provider. The Form CMS–
1728–19 cost report is also used for
annual rate setting and payment
refinement activities, including
developing a home health market
basket. Additionally, the Medicare
Payment Advisory Commission
(MedPAC) uses the home health cost
report data to calculate Medicare
margins, to formulate recommendations
to Congress regarding the HHA PPS, and
to conduct additional analysis of the
HHA PPS. Providers receiving Medicare
reimbursement must provide adequate
cost data based on financial and
statistical records that can be verified by
qualified auditors. Form Number: CMS–
1728–19 (OMB control number: 0938–
0022); Frequency: Yearly; Affected
Public: Business or Other for-Profits,
Not-for-Profit Institutions; Number of
Respondents: 10,196; Total Annual
Responses: 10,196; Total Annual Hours:
1,988,220. (For policy questions
regarding this collection contact LuAnn
Piccione at 410–786–5423.)
2. Type of Information Collection
Request: New Collection; Title of
Information Collection: Electronic
Medical Documentation Interoperability
(EMDI) Pre and Post Pilot Measures
Survey; Use: The EMDI program assists
the Centers for Medicare & Medicaid
Services (CMS) Health Information
Technology (health IT) standards and
interoperability (S&I) initiative, which is
to: (1) Facilitate and expand the secure
transport of interoperable electronic
documentation, (2) utilize and fill in the
gaps in the current standards to achieve
increased level of interoperability
among systems and organizations, and
(3) demonstrate the utility of these
standards by establishing pilot programs
with existing Health Information
Handlers, Health Information Service
Providers (HISP), and health care
providers.
The EMDI Initiative, associated
documentation, and pilots are for the
purposes of evaluating the performance
of CMS policies that involve
interoperability and the collection of
data/information only. The collected
data/information will help CMS, and
the EMDI team in determining the
overall effectiveness of piloting the
EMDI program, as well as assessing each
provider’s current ability to send, and
receive electronic data. Form Number:
CMS–10714 (OMB control number:
0938–New); Frequency: Yearly; Affected
Public: Private Sector (Business or other
E:\FR\FM\24FEN1.SGM
24FEN1
]]>Agencies
[Federal Register Volume 85, Number 36 (Monday, February 24, 2020)]
[Notices]
[Pages 10441-10442]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2020-03584]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
Board of Scientific Counselors, National Center for Injury
Prevention and Control, (BSC, NCIPC)
AGENCY: Centers for Disease Control and Prevention (CDC), Department of
Health and Human Services (HHS).
ACTION: Notice of meeting.
-----------------------------------------------------------------------
SUMMARY: In accordance with the Federal Advisory Committee Act, the CDC
announces the following meeting for the Board of Scientific Counselors,
National Center for Injury Prevention and Control, (BSC, NCIPC). This
meeting is open to the public limited only by the space and ports
available. There will be 2,000 telephone ports available. There will be
a public comment period at the end of the meeting; from 3:00 p.m.-3:45
p.m., EDT.
DATES: The meeting will be held on April 30, 2020, 12:30 p.m. to 3:50
p.m., EDT.
ADDRESSES: Teleconference: Dial-In Number: 1-800-369-3110, Participant
Code: 7563795.
FOR FURTHER INFORMATION CONTACT: Gwendolyn H. Cattledge, Ph.D.,
M.S.E.H., Deputy Associate Director for Science, NCIPC, CDC, 4770
Buford Highway NE, Mailstop F-63, Atlanta, GA 30341, Telephone (770)
488-1430; Email address: [email protected].
SUPPLEMENTARY INFORMATION:
Purpose: The Board will: (1) Conduct, encourage, cooperate with,
and assist other appropriate public health authorities, scientific
institutions, and scientists in the conduct of research,
investigations, experiments, demonstrations, and studies relating to
the causes, diagnosis, treatment, control, and prevention of physical
and mental diseases, and other impairments; (2) assist States and their
political subdivisions in preventing and suppressing communicable and
non-communicable diseases and other preventable conditions and in
promoting health and well-being; and (3) conduct and assist in research
and control activities related to injury. The Board of Scientific
Counselors makes recommendations regarding policies, strategies,
objectives, and priorities; and reviews progress toward injury
prevention goals and provides evidence in injury prevention-related
research and programs. The Board also provides advice on the
appropriate balance of intramural and extramural research, the
structure, progress and performance of intramural programs. The Board
is designed to provide guidance on extramural scientific program
matters, including the: (1) Review of extramural research concepts for
funding opportunity announcements; (2) conduct of Secondary Peer Review
of extramural research grants, cooperative agreements, and contracts
applications received in response to the funding opportunity
announcements as it relates to the Center's programmatic balance and
mission; (3) submission of secondary review recommendations to the
Center Director of applications to be considered for funding support;
(4) review of research portfolios; and (5) review of program proposals.
Matters To Be Considered: The agenda will discuss an update on the
CDC Opioid Prescribing Estimates Project, the Management of Acute and
Chronic Pain: Opportunities for Stakeholder Engagement, and Public
Comments. In addition, an update will be provided on the formation of
the BSC, NCIPC Opioid Workgroup. Agenda items are subject to change as
priorities dictate.
The Director, Strategic Business Initiatives Unit, Office of the
Chief Operating Officer, Centers for Disease Control and Prevention,
has been delegated the authority to sign Federal Register notices
pertaining to
[[Page 10442]]
announcements of meetings and other committee management activities,
for both the Centers for Disease Control and Prevention and the Agency
for Toxic Substances and Disease Registry.
Kalwant Smagh,
Director, Strategic Business Initiatives Unit, Office of the Chief
Operating Officer, Centers for Disease Control and Prevention.
[FR Doc. 2020-03584 Filed 2-21-20; 8:45 am]
BILLING CODE 4163-18-P
